Breast cancer diagnostics market is projected to grow at a CAGR of nearly 7.2% between 2024 and 2032

The global breast cancer diagnostics market was worth around USD 4.42 billion in 2023 and is predicted to grow to around USD 8.27 billion by 2032, at a compound annual growth rate (CAGR) of roughly 7.2% between 2024 and 2032.

Breast cancer diagnostics are the tests, tools, and medical procedures used to detect and confirm breast cancer, helping doctors identify the disease early and choose appropriate treatment. These diagnostics include breast self-examination, clinical examinations, mammography, ultrasound, magnetic resonance imaging, biopsies, and genetic tests. Mammograms are widely used for screening, while ultrasound and other imaging methods help doctors examine suspicious areas more closely. A biopsy can confirm whether abnormal tissue contains cancer cells and identify important tumor characteristics. Growing awareness of breast health, expanding screening programs, and improvements in imaging technology are increasing demand for breast cancer diagnostics worldwide. Healthcare providers are also seeking faster, more accurate diagnostic methods to support earlier treatment decisions. As governments and healthcare systems focus on preventive care and early cancer detection, accessible and reliable diagnostic services are becoming increasingly important.

The breast cancer diagnostics industry keeps expanding because more women are getting screened every year, healthcare providers keep upgrading their imaging equipment, and researchers continue building smarter tests that catch cancer sooner and more reliably.

Browse the full “Breast Cancer Diagnostics Market - By Type (Imaging, Blood Tests, Genomic Tests, and Biopsy), By Product (Platform-based and Instrument-Based), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032-” Report at https://www.zionmarketresearch.com/report/breast-cancer-diagnostics-market

Market Growth Factors

• Growing number of breast cancer cases worldwide: As the disease becomes more common across age groups, hospitals and clinics need a steady supply of dependable diagnostic tools to keep pace with patient volumes.
• Wider government screening initiatives: Public health campaigns encouraging routine mammograms and checkups are bringing more first-time patients into diagnostic centers than ever before.
• Progress in genetic and molecular testing: Laboratories can now detect gene mutations linked to breast cancer, giving doctors a clearer picture of a patient's risk long before symptoms appear.

Restraints

• High cost of advanced diagnostic procedures: Tests involving genomic profiling or specialized imaging remain expensive, which keeps them out of reach for many patients in lower-income regions.
• Shortage of trained specialists: Interpreting mammograms and biopsy results correctly requires experienced radiologists and pathologists, and many regions lack enough of them to meet growing demand.

Breast Cancer Diagnostics Market: Report Scope

Market Segm​entation

The breast cancer diagnostics market can be segmented by test type, product type, end user, disease stage, and region.

By test type, the breast market is segmented into imaging tests, biopsies, blood-based tests, and genetic tests. Imaging tests hold the largest share because mammography is widely used to screen for breast abnormalities before further diagnostic testing.

Based on product type, the breast cancer diagnostics industry is divided into instruments, reagents, and consumables. Instruments dominate the segment as healthcare facilities require advanced mammography, ultrasound, imaging, and biopsy equipment for accurate breast cancer diagnosis.

Based on end user, the breast cancer diagnostics market is classified into hospitals, diagnostic laboratories, and specialty clinics. Hospitals remain the leading end-user segment because they provide comprehensive diagnostic services, including screening, imaging, biopsy, and follow-up care.

Based on disease stage, the market is categorized into early-stage breast cancer and advanced-stage breast cancer. Early-stage diagnosis drives significant demand, as regular screening helps detect abnormalities sooner and allows doctors to begin treatment before the disease progresses.

North America leads the global breast cancer diagnostics market because of its strong healthcare infrastructure, high awareness of breast cancer screening, and widespread access to advanced diagnostic technologies. The United States and Canada have established screening programs that encourage women to undergo regular mammograms and follow-up testing. High healthcare spending allows hospitals and diagnostic centers to invest in modern imaging equipment, biopsy systems, and molecular testing technologies. Growing use of advanced tools, including digital mammography, breast ultrasound, magnetic resonance imaging, and genetic testing, is also supporting regional demand. Strong research activity and partnerships between healthcare providers, technology companies, and research institutions are helping improve diagnostic accuracy. Rising focus on early cancer detection and personalized treatment is further strengthening the region's position in the global market.

Key Market Players

• Hologic Inc.
• Danaher Corporation
• QIANGEN N.V.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Limited
• Argon Medical Devices Inc.
• BD

 Recent Developments

• In June 2026, Siemens Healthineers received FDA clearance for new contrast-enhanced mammography and biopsy capabilities for its Mammomat B.brilliant system, improving imaging and diagnostic confidence for patients with dense breast tissue.
• In May 2026, AstraZeneca and Roche Diagnostics Asia Pacific announced a three-year collaboration to expand AI-powered digital pathology and biomarker testing capabilities for breast and lung cancer across nine Asian markets.

The global Breast Cancer Diagnostics Market is segmented as follows:

By Type

• Imaging
• Blood Tests
• Genomic Tests
• Biopsy

By Product

• Platform-based
• Instrument-based

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com